This may be through bradykinin’s reduction in hepatic fibrosis by inhibiting deposition of fibrogenic components such as pro-collagen and TGF-β1, as shown in rat models of chronic liver injury [17]. Here, TGFB1 is linked to Hepatic fibrosis.